The store will not work correctly when cookies are disabled.
{2-[3-(2-Chloro-phenyl)-quinolin-2-ylsulfanyl]-ethyl}-dimethyl-amine hydrochloride
ID: ALA555008
PubChem CID: 13200268
Max Phase: Preclinical
Molecular Formula: C19H20Cl2N2S
Molecular Weight: 342.90
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)CCSc1nc2ccccc2cc1-c1ccccc1Cl.Cl
Standard InChI: InChI=1S/C19H19ClN2S.ClH/c1-22(2)11-12-23-19-16(15-8-4-5-9-17(15)20)13-14-7-3-6-10-18(14)21-19;/h3-10,13H,11-12H2,1-2H3;1H
Standard InChI Key: FZDBQUNLWSNOGG-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
5.0929 -1.1280 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9097 3.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 -1.5019 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-5.2025 -5.2568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8709 3.6035 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-3.9067 -3.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2071 0.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2049 -3.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2093 3.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2404 -5.8591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1622 -5.8549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5067 1.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5078 3.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
2 5 2 0
2 6 1 0
4 7 1 0
5 8 1 0
7 8 1 0
6 9 1 0
3 10 1 0
9 12 1 0
10 13 1 0
6 14 2 0
11 15 1 0
13 15 1 0
7 16 2 0
8 17 2 0
9 18 2 0
11 19 1 0
11 20 1 0
14 21 1 0
16 22 1 0
17 23 1 0
22 23 2 0
18 24 1 0
21 24 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.90 | Molecular Weight (Monoisotopic): 342.0957 | AlogP: 5.21 | #Rotatable Bonds: 5 |
Polar Surface Area: 16.13 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.46 | CX LogP: 5.36 | CX LogD: 4.27 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.59 | Np Likeness Score: -1.33 |
References
1. Blackburn TP, Cox B, Guildford AJ, Le Count DJ, Middlemiss DN, Pearce RJ, Thornber CW.. (1987) Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogues., 30 (12): [PMID:3681895] [10.1021/jm00395a013] |